Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,060.00
Bid: 2,060.00
Ask: 2,062.00
Change: -30.00 (-1.44%)
Spread: 2.00 (0.097%)
Open: 2,082.00
High: 2,092.00
Low: 2,060.00
Prev. Close: 2,090.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market overview: FTSE 100 finishes up just 0.1%

18 May 2015 09:04

1630: Close The Footsie settled 8.38 points higher at 6,968.87, ending well below the intraday high of 7,015.49 but firmly above the intraday low of 6,931.64. Mining stocks ended broadly higher, though BHP Billiton bucked the trend, while oil and banking shares were providing a drag. Analyst Alastair McCaig from IG said that market "direction [was] distinctly absent despite sufficient corporate newsflow". He said that a sparse economic calendar "provides little incentive for any significant portfolio adjustments". 1529: Spain's Sabadell given EU clearance for TSB acquisition. 1500: The NAHB's gauge of homebuilder confidence retreated to a reading of 54 points in may from 56 in June (consensus: 56). Acting as a backdrop, the Athens Stock Exchange General Index has turned higher to rise by 1.57%. 1426: Shares in Plus 500 are plummeting on reports it has suspended some accounts pending verification that they meet UK anti-money laundering regulations. 1352: The yield on 10-year Greek government bonds is jumping by 82 basis points to 11.44% as markets monitor the situation surrounding Greece. Market News International is reporting the European Central Bank is increasingly concerned at the tone of negotiations. The ECB may decided to raise the haircut it applies on Greek government debt offered up as collateral at the central bank from around 23% at present to between 44% and 80%. RBS's base case continues to be for an early compromise agreement with a partial release of the €7.2bn in aid still left to Greece under its previous rescue programme. However, in the broker's view "capital controls are likely unless an agreement is reached soon." 1338: Shares in Hikma Pharmaceuticals were under pressure on Monday, down 2% after the company said its founder and major shareholder, Samih Darwazah, passed away on Friday 15th May at the age of 85. 1222: A every soft first quarter for US growth is at risk of being followed by a lacklustre rebound in the second quarter, The Wall Street Journal's Jon Hilsenrath wrote over the weekend. The lack of an uptick in consumer spending is especially concerning given improved labour trends, higher income levels and lower gas prices. However, there are signs of underlying strength, Hilsenrath pointed out. June is increasingly off the table and the odds of September are falling too, he added. In any case, once lift-of occurs the pace of tightening will be very gradual, the WSJ Fed watcher pointed out. 1200: Investors are facing "mediocre" returns, "volatile trading rotation & flash crashes" until the flow of US macroeconomic data turns unambiguously robust to allow the Fed "to hike safely," analysts at Bank of America Merrill Lynch wrote on Monday. Hedge, raise some cash, add some gold, own volatility...targets of 0.2% for 5-year bund, 2% for Italy 10-year, 20 on VIX, 2000 for S&P 500 remain Q2 risks, the broker added. 1101: BP's shares are edging 0.1% higher on the back of a 0.4% gain in Brent to $67.07/bbl, as investors shrug off a downgrade by Goldman Sachs. The bank has cut its rating on the integrated oil sector from 'neutral' to 'cautious' and lowered BP specifically from 'neutral' to 'sell', after reducing its near-term forecast for Brent to $65. It also said Brent would fall to $55 by 2020. "For BP, we see limited upstream growth, fewer options left for disposals and an ongoing overhang of the Macondo liability," Goldman said. 1027: "Increased conjecture on the potential unlocking of value should the CCH's territories be re-allocated to other bottlers has widened interest. The core of our investment case has been built on margin expansion, driven by both input costs and opex tailwinds. The recent price run has priced those in: we downgrade the company to HOLD based on valuation," Deutsche Bank analysts say. 1018: "Despite the US data softness, bottoming inflation and recovery in EU/Japan and easy policy keep risk assets steady. We think rates have further to rise and the dollar should resume its rally as US growth recovers. Equity and credit valuations are average, but DM earnings growth is supportive," Morgan Stanley writes today in a research note e-mailed to clients. 1000: After a "euphoric" reaction to its latest IMS and the UK election result Lloyds shares hit a fresh 6.5-year high. Consensus may have some catch-up to do given the lender's robust performance. However, broker Investec had correctly anticipated such an outcome. What's more, on a 12-month view it "expects a combination of statutory downgrades and share indigestion to curtail further progress. Now, with modest implied downside." Investec has downgraded the shares to 'sell' from 'hold' while keeping its target price unchanged at 84p. 0905: Stocks have started the session higher led by gains in Weir Group and Fresnillo. BHP is doing worst on the top flight index as analysts pare their valuations for the firm following the spin-off of its South 32 unit. Credit Suisse's discounted cash flow valuation for the remainder of BHP is $21 share. The Swiss broker has cut its earnings per share forecasts for BHP in fiscal years 2016 and 2017 by approximately 11-12%. Some market commentary is also highlighting how the $9bn valuation fetched by South 32 was less than expected. The price target has been cut to 1,350p from 1,400p. Aveva is the biggest gainer on the FTSE 250 on the back of a Sunday Times report that Schneider Electric, GE or US outfit Emerson might bid for the firm. FTSE 100 up 38.64 to 6,999.00.
Date   Source Headline
5th Mar 20203:57 pmRNSDirector/PDMR Shareholding
4th Mar 20203:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:20 pmRNSHolding(s) in Company
2nd Mar 20203:42 pmRNSHolding(s) in Company
28th Feb 20203:30 pmRNSTotal Voting Rights
27th Feb 20205:18 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSFinal Results
21st Feb 20203:57 pmRNSHolding(s) in Company
21st Feb 202010:05 amRNSHolding(s) in Company
20th Feb 20202:57 pmRNSHolding(s) in Company
18th Feb 20201:51 pmRNSHolding(s) in Company
13th Feb 20202:11 pmRNSHolding(s) in Company
12th Feb 20202:11 pmRNSStatement regarding Weir Chairman
31st Jan 20202:13 pmRNSTotal Voting Rights
27th Jan 20202:49 pmRNSHolding(s) in Company
21st Jan 20203:21 pmRNSHolding(s) in Company
8th Jan 20203:57 pmRNSHolding(s) in Company
7th Jan 20207:00 amRNSPDMR Change
6th Jan 20201:47 pmRNSTotal Voting Rights
19th Dec 20194:22 pmRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSPDMR Change
6th Dec 20197:00 amRNSCapital Markets Event
29th Nov 20193:06 pmRNSTotal Voting Rights
19th Nov 20199:56 amRNSHolding(s) in Company
14th Nov 201911:59 amRNSHolding(s) in Company
5th Nov 20197:00 amRNSInterim Management Statement
31st Oct 201912:24 pmRNSTotal Voting Rights
14th Oct 201910:56 amRNSBlock listing Interim Review
2nd Oct 20199:52 amRNSHolding(s) in Company
1st Oct 20194:31 pmRNSTotal Voting Rights
1st Oct 20193:41 pmRNSHolding(s) in Company
23rd Sep 20192:49 pmRNSHolding(s) in Company
19th Sep 20194:45 pmRNSHolding(s) in Company
19th Sep 20192:17 pmRNSDirector/PDMR Shareholding
18th Sep 20193:39 pmRNSHolding(s) in Company
17th Sep 20193:48 pmRNSHolding(s) in Company
17th Sep 20193:47 pmRNSHolding(s) in Company
6th Sep 20197:10 amRNSNotification of Change in Director's Details
6th Sep 20197:00 amRNSWeir wins record £100m order - Australia
5th Sep 20191:34 pmRNSTransfer of Treasury Shares
2nd Sep 20192:23 pmRNSHolding(s) in Company
30th Aug 20192:50 pmRNSDirector Declaration
30th Aug 20199:21 amRNSTotal Voting Rights
12th Aug 20194:13 pmRNSHolding(s) in Company
7th Aug 20192:55 pmRNSHolding(s) in Company
31st Jul 20194:42 pmRNSDirector/PDMR Shareholding
31st Jul 20191:03 pmRNSTotal Voting Rights
30th Jul 20197:00 amRNSHalf-year Report
15th Jul 20199:56 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSWeir completes sale of Flow Control

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.